rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-4-25
|
pubmed:abstractText |
Suplatast tosilate (IPD) is a newly developed 'anti-allergic' drug. It seems to be a unique compound because of its ability to suppress IgE but not IgG or IgM production in vivo and cytokine production from type 2 helper T cells (Th2) in vitro. However, information on its in vivo effect on an animal model of asthma is limited.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1018-2438
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
116-22
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10705221-Animals,
pubmed-meshheading:10705221-Anti-Allergic Agents,
pubmed-meshheading:10705221-Arylsulfonates,
pubmed-meshheading:10705221-Asthma,
pubmed-meshheading:10705221-Bronchial Hyperreactivity,
pubmed-meshheading:10705221-Bronchial Provocation Tests,
pubmed-meshheading:10705221-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:10705221-Cytokines,
pubmed-meshheading:10705221-Disease Models, Animal,
pubmed-meshheading:10705221-Eosinophilia,
pubmed-meshheading:10705221-Female,
pubmed-meshheading:10705221-Immunoglobulin E,
pubmed-meshheading:10705221-Immunoglobulin G,
pubmed-meshheading:10705221-Lung,
pubmed-meshheading:10705221-Methacholine Chloride,
pubmed-meshheading:10705221-Mice,
pubmed-meshheading:10705221-Ovalbumin,
pubmed-meshheading:10705221-Sulfonium Compounds
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
|
pubmed:affiliation |
Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Ehime, Japan.
|
pubmed:publicationType |
Journal Article
|